BioHouston Breakfast Forum: DNA-Encoded Libraries and AI for Drug Discovery

Join BioHouston on April 9th at the TMC3 Collaborative Building for a Breakfast Forum exploring DNA-Encoded Libraries and AI for Drug Discovery. Advances in DNA-encoded libraries and artificial intelligence are transforming how drug candidates are identified and optimized. This session will explore how these technologies are being integrated to accelerate discovery, enhance decision-making, and open new possibilities across therapeutic development. The forum will feature Gwenn Hansen, Chief Scientific Officer at Nurix Therapeutics and former Baylor College of Medicine faculty member, who will share her perspectives from both academic research and industry innovation.